LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_001378414.1:c.1426C>T
HDAC4
· NP_001365343.1:p.(Pro476Ser)
· NM_001378414.1
GRCh37: chr2:240048259 G>A
·
GRCh38: chr2:239126563 G>A
Gene:
HDAC4
Transcript:
NM_001378414.1
Final call
VUS
PM2 supporting
PP3 supporting
Variant details
Gene
HDAC4
Transcript
NM_001378414.1
Protein
NP_001365343.1:p.(Pro476Ser)
gnomAD AF
1.1154614106124998e-05 (v4.1)
ClinVar
OncoKB
Classification rationale
Interpretation summary
Generated evidence synthesis
1
VUS: PM2 supporting reflects the variant's extremely low gnomAD filtering allele frequency.
2
VUS: PP3 supporting reflects REVEL 0.718 meeting the generic missense threshold.
Final determination:
Under generic ACMG/AMP 2015 fallback rules, PM2 supporting plus PP3 supporting does not satisfy any pathogenic, likely pathogenic, benign, or likely benign combination, so the call is VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PS1 | Not met | Not met: no established pathogenic HDAC4 variant causing p.Pro476Ser was identified, and the variant is absent from ClinVar. |
generic_acmg_combination_rules
|
| PS2 | Not assessed | Not assessed: no documented proband phenotype, family-history assessment, or confirmed maternity and paternity with both parents testing negative. |
|
| PS3 | Not assessed | Not assessed: no variant-specific validated in vitro or in vivo functional assay result is available for NM_001378414.1:c.1426C>T. |
|
| PS4 | Not assessed | Not assessed: gnomAD v4.1 shows 18/1,613,682 alleles, but no affected-case frequency, control comparison, OR/RR, or 95% CI is available. |
gnomad_v4
|
| PM1 | Not assessed | Not assessed: no complete HDAC4 domain assessment establishes that p.Pro476 lies in a critical domain without benign variation. |
hotspots
PMID:33537682
|
| PM2 | Met | Met at supporting strength: gnomAD v4.1 grpmax FAF is 8.78e-06, below the <=0.0001 PM2 threshold. |
gnomad_v4
gnomad_v2
|
| PM3 | Not assessed | Not assessed: no documented recessive disease context or parent/offspring phase result establishes this variant in trans with a pathogenic variant. |
|
| PM4 | N/A | Not applicable: PM4 requires a protein-length change, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | Not met | Not met: zero qualifying pathogenic alternate missense variants at HDAC4 residue 476 were identified for comparison with p.Pro476Ser. |
pm5_candidates
generic_acmg_combination_rules
|
| PM6 | Not assessed | Not assessed: no affected-proband de novo observation or parental testing showing the variant absent without confirmed maternity and paternity. |
|
| PP1 | Not assessed | Not assessed: no affected relatives or family variant testing are documented, so co-segregation and informative meioses cannot be evaluated. |
|
| PP2 | Not assessed | Not assessed: the individual allele frequency is 1.11546e-05, but gene-wide benign-missense constraint and mechanism prevalence are unestablished. |
gnomad_v4
PMID:33537682
|
| PP3 | Met | Met at supporting strength: REVEL 0.718 meets the generic PP3 supporting threshold of >=0.644 for this missense variant. |
revel
|
| PP4 | Not assessed | Not assessed: no patient phenotype, family history, or disease-specific clinical description is available to evaluate PP4. |
|
| PP5 | Not met | Not met: ClinVar has no exact-variant record, with 0 submissions and 0 expert-panel submissions supporting pathogenicity. |
|
| BA1 | Not met | Not met: gnomAD v4.1 grpmax FAF is 8.78e-06 (0.000878%), below the >=0.05 BA1 threshold. |
gnomad_v4
gnomad_v2
|
| BS1 | Not met | Not met: gnomAD v4.1 grpmax FAF is 8.78e-06, far below the generic BS1 default threshold of >=0.01. |
gnomad_v4
gnomad_v2
|
| BS2 | Not assessed | Not assessed: no documented healthy adult carrying the variant and no inheritance or early-onset full-penetrance context is available. |
gnomad_v4
gnomad_v2
|
| BS3 | Not assessed | Not assessed: no variant-specific validated functional result shows that NM_001378414.1:c.1426C>T has no damaging effect. |
|
| BS4 | Not assessed | Not assessed: no tested affected relatives are documented, so lack of segregation and possible phenocopies cannot be evaluated. |
|
| BP1 | Not assessed | Not assessed: HDAC4 truncating/deletion disease and a missense disorder are documented, but predominance of truncating disease variants is unestablished. |
PMID:20691407
PMID:33537682
generic_acmg_combination_rules
|
| BP2 | Not assessed | Not assessed: no documented phase result shows this variant in trans or cis with a pathogenic variant in an affected individual. |
|
| BP3 | N/A | Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | Not met | Not met: REVEL 0.718 exceeds the generic BP4 supporting threshold of <=0.29, so the missense result is indeterminate for benign computational evidence. |
revel
|
| BP5 | Not assessed | Not assessed: no case-level evidence shows that the variant occurred with an alternate molecular basis for the disease. |
|
| BP6 | Not met | Not met: ClinVar has no exact-variant record, with 0 submissions and 0 expert-panel submissions supporting benignity. |
|
| BP7 | N/A | Not applicable: BP7 requires a synonymous variant, and this is a missense variant. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.